Quantification of liver function by linearization of a two‐compartment model of gadoxetic acid uptake using dynamic contrast‐enhanced magnetic resonance imaging
dc.contributor.author | Simeth, Josiah | |
dc.contributor.author | Johansson, Adam | |
dc.contributor.author | Owen, Dawn | |
dc.contributor.author | Cuneo, Kyle | |
dc.contributor.author | Mierzwa, Michelle | |
dc.contributor.author | Feng, Mary | |
dc.contributor.author | Lawrence, Theodore S. | |
dc.contributor.author | Cao, Yue | |
dc.date.accessioned | 2018-06-11T17:59:02Z | |
dc.date.available | 2019-08-01T19:53:22Z | en |
dc.date.issued | 2018-06 | |
dc.identifier.citation | Simeth, Josiah; Johansson, Adam; Owen, Dawn; Cuneo, Kyle; Mierzwa, Michelle; Feng, Mary; Lawrence, Theodore S.; Cao, Yue (2018). "Quantification of liver function by linearization of a two‐compartment model of gadoxetic acid uptake using dynamic contrast‐enhanced magnetic resonance imaging." NMR in Biomedicine 31(6): n/a-n/a. | |
dc.identifier.issn | 0952-3480 | |
dc.identifier.issn | 1099-1492 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/144228 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | Springer US | |
dc.subject.other | hepatobiliary contrast | |
dc.subject.other | imaging informed treatment planning | |
dc.subject.other | liver function | |
dc.subject.other | quantitative imaging | |
dc.subject.other | Gd chelate based contrast agents | |
dc.subject.other | DCE‐MRI | |
dc.title | Quantification of liver function by linearization of a two‐compartment model of gadoxetic acid uptake using dynamic contrast‐enhanced magnetic resonance imaging | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Physics | |
dc.subject.hlbsecondlevel | Electrical Engineering | |
dc.subject.hlbtoplevel | Engineering | |
dc.subject.hlbtoplevel | Science | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/144228/1/nbm3913.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/144228/2/nbm3913_am.pdf | |
dc.identifier.doi | 10.1002/nbm.3913 | |
dc.identifier.source | NMR in Biomedicine | |
dc.identifier.citedreference | Wang H, Feng M, Frey KA, Ten Haken RK, Lawrence TS, Cao Y. Predictive models for regional hepatic function based upon 99m Tc‐IDA SPECT and local radiation dose for physiological adaptive RT. Int J Radiat Oncol Biol Phys. 2013; 86 ( 5 ): 1000 ‐ 1006. | |
dc.identifier.citedreference | Cao Y, Wang H, Johnson TD, et al. Prediction of liver function by using magnetic resonance‐based portal venous perfusion imaging. Int J Radiat Oncol Biol Phys. 2013; 85 ( 1 ): 258 ‐ 263. | |
dc.identifier.citedreference | Bormann RL, da Rocha EL, Kierzenbaum ML, Pedrassa BC, Torres LR, D’Ippolito G. The role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a review. Radiol Bras. 2015; 48 ( 1 ): 43 ‐ 51. | |
dc.identifier.citedreference | Yamada A. Quantitative evaluation of liver function within MR imaging. In: El‐Baz AS, Saba L, Suri J, eds. Abdomen and Thoracic Imaging. Town: Springer US; 2014: 233 ‐ 251. | |
dc.identifier.citedreference | Sourbron S, Sommer WH, Reiser MF, Zech CJ. Combined quantification of liver perfusion and function with dynamic gadoxetic acid‐enhanced MR imaging. Radiology. 2012; 263 ( 3 ): 874 ‐ 883. | |
dc.identifier.citedreference | Stenmark MH, Cao Y, Wang H, et al. Indocyanine green for individualized assessment of functional liver reserve in patients undergoing liver radiation therapy. Int J Radiat Oncol Biol Phys. 2013; 87 ( 2 ): S26 ‐ S27. | |
dc.identifier.citedreference | Van Beers BE, Pastor CM, Hussain HK. Primovist, Eovist: what to expect? J Hepatol. 2012; 57 ( 2 ): 421 ‐ 429. | |
dc.identifier.citedreference | Armbruster M, Zech CJ, Sourbron S, et al. Diagnostic accuracy of dynamic gadoxetic‐acid‐enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms. J Magn Reson Imaging. 2014; 40 ( 2 ): 457 ‐ 466. | |
dc.identifier.citedreference | Chandarana H, Block TK, Ream J, et al. Estimating liver perfusion from free‐breathing continuously acquired dynamic gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced acquisition with compressed sensing reconstruction. Invest Radiol. 2015; 50 ( 2 ): 88 ‐ 94. | |
dc.identifier.citedreference | Sommer WH, Sourbron S, Huppertz A, Ingrisch M, Reiser MF, Zech CJ. Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approaches. Abdom Imaging. 2012; 37 ( 2 ): 164 ‐ 179. | |
dc.identifier.citedreference | Yoneyama T, Fukukura Y, Kamimura K, et al. Efficacy of liver parenchymal enhancement and liver volume to standard liver volume ratio on Gd‐EOB‐DTPA‐enhanced MRI for estimation of liver function. Eur Radiol. 2014; 24 ( 4 ): 857 ‐ 865. | |
dc.identifier.citedreference | Johansson A, Balter J, Feng M, Cao Y. An overdetermined system of transform equations in support of robust DCE‐MRI registration with outlier rejection. Tomography: J Imaging Res. 2016; 2 ( 3 ): 188 ‐ 196. | |
dc.identifier.citedreference | Patlak CS, Blasberg RG. Graphical evaluation of blood‐to‐brain transfer constants from multiple‐time uptake data. Generalizations. J Cereb Blood Flow Metab. 1985; 5 ( 4 ): 584 ‐ 590. | |
dc.identifier.citedreference | Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence‐based approach—the ALBI grade. J Clin Oncol. 2015; 33 ( 6 ): 550 ‐ 558. | |
dc.identifier.citedreference | Wu VW, Epelman MA, Wang H, et al. Optimizing global liver function in radiation therapy treatment planning. Phys Med Biol. 2016; 61 ( 17 ): 6465 ‐ 6484. | |
dc.identifier.citedreference | Bennink RJ, Cieslak KP, van Delden OM, et al. Monitoring of total and regional liver function after SIRT. Front Oncol. 2014; 4. | |
dc.identifier.citedreference | Sørensen M, Mikkelsen KS, Frisch K, Villadsen GE, Keiding S. Regional metabolic liver function measured by 2‐[ 18 F]fluoro‐2‐deoxy‐ d ‐galactose PET/CT in patients with cirrhosis. J Hepatol. 2013; 58 ( 6 ): 1119 ‐ 1124. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.